This article is more than 5 years old. Information may no longer be current.
Physician-researcher joins City of Hope
Click Here to Manage Email Alerts
Guido Marcucci, MD, a renowned physician and researcher, has accepted a leadership appointment at City of Hope’s new Hematologic Malignancies and Stem Cell Transplantation Institute.
Marcucci will serve as director of the Gehr Family Center for Leukemia Research, as well as chief of the division of hematopoietic stem cell and leukemia research.
Guido Marucci
Marcucci, who also will serve as professor of hematology and hematopoietic cell transplantation, will guide research into improved treatments for leukemia and other hematologic malignancies.
“City of Hope is extremely fortunate to have a scientist and physician of Dr. Marcucci’s caliber and accomplishments as chief of our new leukemia center,” Steven T. Rosen, provost and chief scientific officer at City of Hope, said in a press release. “With his guidance and vision, we will be able to develop and bring to fruition revolutionary new treatments for leukemia and other diseases. His experience in leukemia and hematopoietic stem cell transplantation in particular will help us change the future for both current and future patients.”
Marcucci is recognized as a leader in the treatment of lymphoma, leukemia, myeloma and other blood cancers. He previously served as chair of medicine in the college of medicine and associate director for translational research at The Ohio State University Comprehensive Cancer Center.
“City of Hope is known world-wide as a pioneer and leader in the treatment of leukemia and other diseases, with scientists, physicians and leaders all working together to change the future of cancer treatment,” Marcucci said in a press release. “I’m extremely pleased to join such a remarkable institution as it expands its commitment to developing new treatment approaches.”